James Collins

James Collins

Director/Board Member bei SENTI BIOSCIENCES, INC.

Vermögen: 288 911 $ am 31.03.2024

58 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

James J.
Collins
is the founder of Cellicon Biotechnologies, Inc. (founded in 2000), Corvium, Inc. (founded in 2009), Synlogic Operating Co., Inc. (founded in 2014), EnBiotix, Inc. (founded in 2012), Senti Sub I, Inc. (founded in 2016), Synlogic, Inc. (founded in 2017), Sherlock Biosciences, Inc. (founded in 2018), and Cellarity Inc. (founded in 2017).
He currently holds the position of Independent Director at Fulcrum Therapeutics, Inc. (since 2017), Independent Director at Orion Biotech Opportunities Corp., Independent Director at Senti Biosciences, Inc. (since 2022), Professor at Harvard University, Professor at Massachusetts Institute of Technology (since 2014), and Member of the National Academy of Sciences, American Academy of Arts & Sciences, National Academy of Engineering, National Academy of Medicine (United States), Excel Medical Ventures LLC (Board of Strategic Advisors), The Broad Institute, Inc., Harvard Mit Health Sciences & Technology, and National Academy of Inventors.
He previously held the position of Chief Scientific Officer at Aitia, Inc. (from 2008 to 2012) and Professor at Boston University (from 1990 to 2014).
He completed his undergraduate degree at the College of the Holy Cross (Massachusetts) and obtained a doctorate degree from the University of Oxford.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
27.06.2023 23 571 ( 0,04% ) 222 510 $ 31.03.2024
16.06.2023 176 130 ( 0,38% ) 66 401 $ 31.03.2024

Aktive Positionen von James Collins

UnternehmenPositionBeginn
ORION BIOTECH OPPORTUNITIES CORP. Director/Board Member -
FULCRUM THERAPEUTICS, INC. Director/Board Member 01.01.2017
SENTI BIOSCIENCES, INC. Director/Board Member 08.06.2022
Massachusetts Institute of Technology Corporate Officer/Principal 01.12.2014
Corporate Officer/Principal -
Director/Board Member -
Harvard Mit Health Sciences & Technology Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Alle aktiven Positionen von James Collins

Ehemalige bekannte Positionen von James Collins

UnternehmenPositionEnde
░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░ -
Sehen Sie sich die Erfahrung von James Collins im Detail an

Ausbildung von James Collins

College of the Holy Cross (Massachusetts) Undergraduate Degree
University of Oxford Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von James Collins im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

25

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
FULCRUM THERAPEUTICS, INC.

Health Technology

SYNLOGIC, INC.

Health Technology

Private Unternehmen17

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Finance

Health Technology

Technology Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Senti Biosciences, Inc.

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. James Collins